Predicted Trait | |
Reported Trait | Malignant neoplasm of testis |
Mapped Trait(s) | testicular carcinoma (EFO_0005088) |
Additional Trait Information | PheCode 187.2 |
Score Construction | |
PGS Name | PRSWEB_PHECODE187.2_GWAS-Catalog-r2019-05-03-X187.2_PT_MGI_20200608 |
Development Method | |
Name | Pruning and Thresholding (P+T) |
Parameters | LD Clumping (MAF >= 1%, r^2 <= 0.1) & P<=2.51e-11 |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 22 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000118 |
Citation (link to publication) | Fritsche LG et al. Am J Hum Genet (2020) |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
---|---|---|---|
GWAS Catalog: GCST000414 Europe PMC: 19483681 | 2,165 individuals | European | NR |
GWAS Catalog: GCST000701 Europe PMC: 20543847 | 5,926 individuals | European | NR |
GWAS Catalog: GCST002022 Europe PMC: 23666240 | 5,932 individuals | European | NR |
GWAS Catalog: GCST002023 Europe PMC: 23666239 | 1,638 individuals | European | NR |
GWAS Catalog: GCST002855 Europe PMC: 25877299 | 8,013 individuals | European | NR |
GWAS Catalog: GCST003246 Europe PMC: 26503584 | 5,932 individuals | European | NR |
GWAS Catalog: GCST003247 Europe PMC: 26503584 | 5,932 individuals | European | NR |
GWAS Catalog: GCST004635 Europe PMC: 28604728 | 24,573 individuals | European | NR |
GWAS Catalog: GCST004713 Europe PMC: 28604732 | 17,528 individuals | European | NR |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
Phenotype Definitions & Methods
|
Age of Study Participants
|
Participant Follow-up Time
|
Additional Ancestry Description
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
Europe PMC: 32991828 | [
| European | MGI | PheCode:187.2; ICD9CM:186.0, 186.9, V10.47; ICD10CM:C62, C62.0, C62.00, C62.01, C62.02, C62.1, C62.1... 0, C62.11, C62.12, C62.9, C62.90, C62.91, C62.92Show more | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source
|
Trait
|
PGS Effect Sizes (per SD change) |
Classification Metrics
|
Other Metrics
|
Covariates Included in the Model
|
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001288 | PSS000553| European Ancestry| 755 individuals | PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) | Reported Trait: Malignant neoplasm of testis | OR: 1.625 [1.27, 2.079] β: 0.485 (0.126) | AUROC: 0.625 [0.557, 0.693] | Nagelkerke's Pseudo-R²: 0.044 Brier score: 0.084 Odds Ratio (OR, top 1% vs. Rest): 6.05 [1.73, 21.2] | age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE187.2_GWAS-Catalog-r2019-05-03-X187.2_PT_MGI_20200608 |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods
|
Participant Follow-up Time
|
Sample Numbers
|
Age of Study Participants
|
Sample Ancestry
|
Additional Ancestry Description
|
Cohort(s)
|
Additional Sample/Cohort Information
|
---|---|---|---|---|---|---|---|---|
PSS000553 | PheCode:187.2; ICD9CM:186.0, 186.9, V10.47; ICD10CM:C62, C62.0, C62.00, C62.01, C62.02, C62.1, C62.1... 0, C62.11, C62.12, C62.9, C62.90, C62.91, C62.92Show more | — | [
| — | European | — | MGI | — |